| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Stem Cells | 18 | 2022 | 195 | 1.930 |
Why?
|
| Carcinogenesis | 6 | 2020 | 135 | 1.880 |
Why?
|
| Glioblastoma | 18 | 2023 | 161 | 1.780 |
Why?
|
| Brain Neoplasms | 17 | 2023 | 318 | 1.720 |
Why?
|
| Oncogenes | 3 | 2019 | 70 | 1.560 |
Why?
|
| Epigenesis, Genetic | 7 | 2020 | 407 | 1.190 |
Why?
|
| Sequence Analysis, DNA | 2 | 2025 | 414 | 0.860 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2025 | 312 | 0.790 |
Why?
|
| DNA | 1 | 2025 | 858 | 0.640 |
Why?
|
| Selection, Genetic | 1 | 2020 | 90 | 0.620 |
Why?
|
| Succinate Dehydrogenase | 1 | 2019 | 16 | 0.610 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2019 | 20 | 0.600 |
Why?
|
| Chromosome Aberrations | 1 | 2019 | 70 | 0.600 |
Why?
|
| Glucose Transporter Type 3 | 2 | 2021 | 4 | 0.580 |
Why?
|
| Glioma | 3 | 2017 | 101 | 0.570 |
Why?
|
| DNA Methylation | 5 | 2020 | 302 | 0.510 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2025 | 583 | 0.500 |
Why?
|
| Chromatin | 3 | 2017 | 641 | 0.480 |
Why?
|
| Insulator Elements | 1 | 2015 | 5 | 0.470 |
Why?
|
| Mutation | 3 | 2025 | 2661 | 0.470 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2015 | 28 | 0.460 |
Why?
|
| Cell Line, Tumor | 10 | 2025 | 1565 | 0.370 |
Why?
|
| Glucose | 1 | 2013 | 476 | 0.320 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2019 | 119 | 0.320 |
Why?
|
| Cell Adhesion Molecules | 3 | 2015 | 95 | 0.320 |
Why?
|
| CCCTC-Binding Factor | 2 | 2019 | 41 | 0.270 |
Why?
|
| Neoplasms | 1 | 2017 | 1368 | 0.250 |
Why?
|
| Molecular Targeted Therapy | 3 | 2017 | 128 | 0.250 |
Why?
|
| Humans | 29 | 2025 | 65140 | 0.250 |
Why?
|
| Brain | 2 | 2016 | 1605 | 0.240 |
Why?
|
| CRISPR-Cas Systems | 3 | 2019 | 369 | 0.230 |
Why?
|
| Bromodeoxyuridine | 1 | 2025 | 44 | 0.230 |
Why?
|
| Genome, Mitochondrial | 1 | 2025 | 13 | 0.230 |
Why?
|
| Radiation Tolerance | 1 | 2025 | 56 | 0.230 |
Why?
|
| Cell Proliferation | 8 | 2017 | 1038 | 0.230 |
Why?
|
| Base Pairing | 1 | 2025 | 44 | 0.230 |
Why?
|
| Repressor Proteins | 4 | 2019 | 351 | 0.220 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 86 | 0.220 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2025 | 71 | 0.210 |
Why?
|
| Mice | 12 | 2025 | 11119 | 0.210 |
Why?
|
| Animals | 19 | 2025 | 21345 | 0.210 |
Why?
|
| Mice, Nude | 5 | 2016 | 286 | 0.200 |
Why?
|
| Oligonucleotides | 1 | 2025 | 229 | 0.200 |
Why?
|
| Tumor Cells, Cultured | 5 | 2015 | 426 | 0.190 |
Why?
|
| Cell Survival | 5 | 2017 | 587 | 0.190 |
Why?
|
| Medulloblastoma | 1 | 2022 | 13 | 0.180 |
Why?
|
| Cerebellar Neoplasms | 1 | 2022 | 11 | 0.180 |
Why?
|
| Receptors, Cell Surface | 2 | 2015 | 431 | 0.180 |
Why?
|
| RNA | 1 | 2025 | 426 | 0.180 |
Why?
|
| Gene Expression Profiling | 3 | 2020 | 794 | 0.170 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2021 | 52 | 0.170 |
Why?
|
| Stochastic Processes | 1 | 2020 | 28 | 0.160 |
Why?
|
| Fibroblast Growth Factor 4 | 1 | 2019 | 7 | 0.150 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2019 | 9 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 203 | 0.150 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2019 | 35 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2019 | 32 | 0.150 |
Why?
|
| Gene Silencing | 2 | 2020 | 433 | 0.150 |
Why?
|
| Transcription, Genetic | 3 | 2018 | 907 | 0.150 |
Why?
|
| Typhoid Fever | 1 | 2018 | 21 | 0.140 |
Why?
|
| Salmonella typhi | 1 | 2018 | 19 | 0.140 |
Why?
|
| Up-Regulation | 2 | 2017 | 374 | 0.140 |
Why?
|
| Cell Adhesion | 2 | 2015 | 218 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2019 | 500 | 0.130 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2017 | 13 | 0.130 |
Why?
|
| Cells, Cultured | 3 | 2017 | 2188 | 0.130 |
Why?
|
| Purines | 1 | 2017 | 43 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 95 | 0.130 |
Why?
|
| Telomeric Repeat Binding Protein 2 | 2 | 2014 | 3 | 0.130 |
Why?
|
| Base Sequence | 2 | 2016 | 1332 | 0.120 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 9 | 0.120 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2016 | 9 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 113 | 0.120 |
Why?
|
| Glutarates | 1 | 2015 | 11 | 0.120 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 250 | 0.120 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2015 | 18 | 0.120 |
Why?
|
| Receptors, Transferrin | 1 | 2015 | 33 | 0.120 |
Why?
|
| Ferritins | 1 | 2015 | 30 | 0.120 |
Why?
|
| Immune Evasion | 1 | 2016 | 71 | 0.110 |
Why?
|
| Cdc20 Proteins | 1 | 2015 | 6 | 0.110 |
Why?
|
| Connexins | 1 | 2015 | 9 | 0.110 |
Why?
|
| Connexin 43 | 1 | 2015 | 14 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 217 | 0.110 |
Why?
|
| Gene Editing | 1 | 2019 | 328 | 0.110 |
Why?
|
| Heterografts | 4 | 2015 | 66 | 0.110 |
Why?
|
| CpG Islands | 1 | 2015 | 219 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 236 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2015 | 324 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2025 | 713 | 0.110 |
Why?
|
| Iron | 1 | 2015 | 155 | 0.110 |
Why?
|
| Phenotype | 2 | 2015 | 1233 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 205 | 0.110 |
Why?
|
| Protein Binding | 2 | 2016 | 1640 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 64 | 0.110 |
Why?
|
| CD36 Antigens | 1 | 2014 | 26 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 116 | 0.110 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 182 | 0.100 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 109 | 0.100 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 18 | 0.100 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2013 | 31 | 0.100 |
Why?
|
| Binding Sites | 1 | 2015 | 921 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 402 | 0.100 |
Why?
|
| Biological Transport | 1 | 2013 | 292 | 0.090 |
Why?
|
| Signal Transduction | 6 | 2022 | 3153 | 0.090 |
Why?
|
| Biomarkers, Tumor | 2 | 2016 | 524 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1630 | 0.080 |
Why?
|
| Mitochondria | 1 | 2015 | 410 | 0.080 |
Why?
|
| Cellular Microenvironment | 1 | 2011 | 23 | 0.080 |
Why?
|
| Neoplasm Transplantation | 3 | 2015 | 167 | 0.080 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2009 | 9 | 0.080 |
Why?
|
| Macrophages | 1 | 2015 | 1038 | 0.070 |
Why?
|
| Bevacizumab | 2 | 2023 | 60 | 0.070 |
Why?
|
| Female | 7 | 2025 | 34018 | 0.070 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2017 | 19 | 0.060 |
Why?
|
| Integrin beta3 | 1 | 2025 | 8 | 0.060 |
Why?
|
| Tumor Microenvironment | 2 | 2017 | 183 | 0.060 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2025 | 33 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2015 | 202 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2025 | 222 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 2 | 2015 | 132 | 0.050 |
Why?
|
| Vasoconstriction | 1 | 2004 | 22 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2015 | 233 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 49 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2004 | 78 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 240 | 0.050 |
Why?
|
| DNA Replication | 1 | 2025 | 247 | 0.050 |
Why?
|
| Cell Movement | 1 | 2025 | 482 | 0.050 |
Why?
|
| Phosphofructokinase-1 | 1 | 2023 | 1 | 0.050 |
Why?
|
| Software | 1 | 2025 | 400 | 0.050 |
Why?
|
| Osteopontin | 1 | 2021 | 21 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 116 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 3485 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 428 | 0.040 |
Why?
|
| Apoptosis | 2 | 2015 | 1098 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2014 | 1386 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 33 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 981 | 0.030 |
Why?
|
| Genome, Human | 1 | 2019 | 237 | 0.030 |
Why?
|
| Ribose-Phosphate Pyrophosphokinase | 1 | 2017 | 1 | 0.030 |
Why?
|
| Guanosine Monophosphate | 1 | 2017 | 2 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 616 | 0.030 |
Why?
|
| Adenosine Monophosphate | 1 | 2017 | 29 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 59 | 0.030 |
Why?
|
| Metabolomics | 1 | 2017 | 63 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2016 | 28 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 121 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 687 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 94 | 0.030 |
Why?
|
| Arginase | 1 | 2016 | 7 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 130 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 52 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2016 | 110 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2016 | 153 | 0.030 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2015 | 6 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 197 | 0.030 |
Why?
|
| Gap Junctions | 1 | 2015 | 18 | 0.030 |
Why?
|
| Transferrin | 1 | 2015 | 70 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2024 | 0.030 |
Why?
|
| Dynamins | 1 | 2015 | 13 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 58 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2015 | 133 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 2015 | 25 | 0.030 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2015 | 40 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2015 | 139 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 128 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 211 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2016 | 398 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2015 | 154 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 133 | 0.030 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2014 | 4 | 0.030 |
Why?
|
| Cell Surface Display Techniques | 1 | 2014 | 3 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 146 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2014 | 18 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 180 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2014 | 48 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2014 | 33 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 611 | 0.030 |
Why?
|
| Tubulin | 1 | 2014 | 73 | 0.030 |
Why?
|
| Phthalazines | 1 | 2013 | 3 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 526 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 513 | 0.030 |
Why?
|
| Genomics | 1 | 2017 | 384 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 643 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2013 | 47 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2013 | 26 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2015 | 576 | 0.020 |
Why?
|
| Histones | 1 | 2016 | 494 | 0.020 |
Why?
|
| Piperazines | 1 | 2013 | 86 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 415 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 79 | 0.020 |
Why?
|
| Monocytes | 1 | 2015 | 361 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 355 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 868 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 962 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 237 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 790 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 663 | 0.020 |
Why?
|
| DNA Repair | 1 | 2013 | 262 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 856 | 0.020 |
Why?
|
| DNA Damage | 1 | 2013 | 297 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 852 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 42 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 72 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 1784 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 82 | 0.020 |
Why?
|
| Peptides | 1 | 2014 | 591 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1220 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 234 | 0.020 |
Why?
|
| Oxygen | 1 | 2011 | 319 | 0.020 |
Why?
|
| Drug Design | 1 | 2009 | 137 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 250 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1574 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2014 | 918 | 0.020 |
Why?
|
| Male | 3 | 2017 | 31047 | 0.020 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2004 | 12 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2004 | 18 | 0.010 |
Why?
|
| Arterioles | 1 | 2004 | 7 | 0.010 |
Why?
|
| Phenylephrine | 1 | 2004 | 18 | 0.010 |
Why?
|
| Thiazolidines | 1 | 2004 | 14 | 0.010 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2004 | 23 | 0.010 |
Why?
|
| Thiazoles | 1 | 2004 | 45 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2004 | 70 | 0.010 |
Why?
|
| Polymers | 1 | 2004 | 332 | 0.010 |
Why?
|